# MP Biomedicals Asia Pacific Pte Ltd – FDA Inspection, Mar 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/d5bda2f5-0d87-4694-ab4d-3f50a76794bf
Source feed: FDA_Inspections

> FDA inspection 1265006 of MP Biomedicals Asia Pacific Pte Ltd, March 21, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 820. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265006
- Company Name: MP Biomedicals Asia Pacific Pte Ltd
- Inspection Date: 2025-03-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Documents

- [FDA Inspection 1077526 - 2018-12-14](https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/2da55fc1-c489-4d12-9439-cfaeeb984d09)
- [FDA Inspection 1029898 - 2017-07-13](https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/9eaf2846-f691-4829-9b12-89ec8c9ef454)
- [FDA Inspection 1002457 - 2016-11-07](https://www.keypedia.com/records/fda_inspections/mp-biomedicals-asia-pacific-pte-ltd/ef8f77ac-cf01-4e60-9907-350dbaec8508)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)
- [Issuing Officer](https://www.keypedia.com/people/nisha-c-patel/1b38764f-c7bc-4f90-9af1-54989ad6d59c)

Company: https://www.keypedia.com/companies/mp-biomedicals-asia-pacific-pte-ltd/75e41e7a-d050-40c9-b78a-0aae42525974

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
